ARTICLE | Company News
Entelos completes asthma deal with Bayer
October 4, 2000 7:00 AM UTC
Entelos (Menlo Park, Calif.) evaluated an IL-4 receptor antagonist from Bayer (DAX:BAYG) as a potential treatment for asthma. Entelos used its predictive PhysioLab technology, which integrates relevan...